Formulations of non-steroidal anti-inflammatory agents to...

Details Formulations of non-steroidal anti-inflammatory agents to... Formulations of non-steroidal anti-inflammatory agents to...

A - Human Necessities

61

K

A61K 31/19 (2006.01)

Patent

CA 2527121

Methods for the use of NSAIs in combination with anecortave acetate are disclosed for preventing and treating pathologic ocular angiogenesis and associated edema, retinal edema, PPDR or NPDR.

L'invention concerne des méthodes d'utilisation d'AINS associés à l'acétate d'anécortave pour prévenir et traiter l'angiogenèse oculaire pathologique et l'oedème associé, l'oedème rétinien, la rétinopathie diabétique pré-proliférative ou la rétinopathie diabétique non proliférative.

Affiliated with

Also associated with

Rating

Formulations of non-steroidal anti-inflammatory agents to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulations of non-steroidal anti-inflammatory agents to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations of non-steroidal anti-inflammatory agents to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2052030